Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ID50 (functional) | = 0.83 uM | Compound was evaluated in vitro for antitumor activity in CCRF-CEM culture of human leukemic lymphocytes | ChEMBL. | 3806576 |
ID50 (functional) | = 0.83 uM | Compound was evaluated in vitro for antitumor activity in CCRF-CEM culture of human leukemic lymphocytes | ChEMBL. | 3806576 |
ILS (functional) | = 136 % | Compound was evaluated in vivo for antileukemic activity in B6D2F1 male mice | ChEMBL. | 3806576 |
ILS (functional) | = 136 % | Compound was evaluated in vivo for antileukemic activity in B6D2F1 male mice | ChEMBL. | 3806576 |
T1/2 (ADMET) | = 38 min | Half-life time of the compound | ChEMBL. | 3806576 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.